Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme
André Otávio Peres Protzek(Universidade Estadual de Campinas (UNICAMP)), Antônio C. Boschero(Universidade Estadual de Campinas (UNICAMP)), José Maria Costa-Júnior(Université Libre de Bruxelles), Alex Rafacho(Universidade Federal de Santa Catarina), Ana Paula Gameiro Cappelli(Universidade Estadual de Campinas (UNICAMP)), Flávia M. Paula(Universidade Estadual de Campinas (UNICAMP)), Everardo M. Carneiro(Universidade Estadual de Campinas (UNICAMP)), Sandra Mara Ferreira(Universidade Estadual de Campinas (UNICAMP)), Mirian Ayumi Kurauti(Universidade Estadual de Campinas (UNICAMP)), Jane Cristina de Souza(Universidade Estadual de Campinas (UNICAMP)), Luiz Fernando de Rezende(Universidade Estadual de Campinas (UNICAMP))
The Journal of Steroid Biochemistry and Molecular Biology
September 16, 2015
Cited by 50
Related Papers
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
|Journal of Endocrinology|2014|214
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
|Journal of Endocrinology|2011|119
Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy
|Journal of Endocrinology|2004|111
High doses of dexamethasone induce increased β-cell proliferation in pancreatic rat islets
|American Journal of Physiology-Endocrinology and Metabolism|2009|106